Activator and Type II Diabetics

Type II Diabetes Clinical Trial

Official title:

Effect of Activator Methods Technique on Lowering A1c Levels in Type II Diabetics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01782092
• Other study ID #: I-009
• Status: Completed
• Phase: N/A
• First received: January 30, 2013
• Last updated: April 19, 2016
• Start date: August 2012
• Est. completion date: August 2014

Study information

• Verified date: September 2015
• Source: Life University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study (15-subject prospective case series) is to examine the effects of the Activator Methods technique on decreasing A1c levels in patients with type II Diabetes Mellitus (aka adult-onset diabetes).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5
• Est. completion date: August 2014
• Est. primary completion date: August 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 30 Years to 60 Years

Eligibility

Inclusion Criteria:

• Subjects will be eligible to participate in the study if they are between the ages of 30-60 and are clinically diagnosed with Type II diabetes by their primary care providers or endocrinologists (diagnosis usually based on FPG > 126 mg/dL on two occasions).

• Participants must have been diagnosed for at least one year and currently be under medical supervision for the disease.

• They must also have an A1c measurement above 7%, which indicates less than optimal management of the disease.

Exclusion Criteria:

• The study will exclude pregnant women;

• those with co-morbidities affecting life expectancy (e.g. malignancy, CVD); uncontrolled hypertension (> 150/100 mmHg);

• serious trauma (e.g. MVA) within the previous 12 months;

• diagnosed bleeding/clotting disorders; those currently under chiropractic care or having contraindications to Activator care (e.g. vertebral fracture, infection, active inflammatory arthritis, severe osteoporosis).

The presence of these exclusions will be determined during the history and exam procedures. All female subjects will be asked to take precautions during their participation in the study to avoid becoming pregnant.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Diabetes Mellitus, Type 2
• Type II Diabetes

Intervention

Other:
• Chiropractic Adjustment
Chiropractic adjustments will be administered using Activator Methods Basic protocol

Locations

Country	Name	City	State
United States	Life University	Marietta	Georgia

Sponsors (1)

Lead Sponsor	Collaborator
Life University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lowered A1C Levels		6 months	No